Literature DB >> 9890456

Immunohistochemical evaluation of the small and large proteoglycans in pleomorphic adenoma of salivary glands.

M Zhao1, T Takata, I Ogawa, T Yada, K Kimata, H Nikai.   

Abstract

This study investigated the immunolocalization of small and large proteoglycans (PGs), including decorin, biglycan, PG-M/versican and aggrecan, in salivary pleomorphic adenoma (PA) using monoclonal and polyclonal antibodies. In addition, a polyclonal antibody, A0082, recognizing blood vessels was also used to help identify truly mesenchymal tissues in PA. Decorin reactivity was detected only in tumor capsule and interstitial tissue of non-neoplastic salivary gland, but not in the tumor tissue. Biglycan was frequently revealed throughout the matrix of small chondroid regions and in the peripheral portion of larger chondroid regions. PG-M/versican was mainly localized to the truly mesenchymal tissues in PA and the innermost portion of tumor capsule. On the contrary, aggrecan was extensively expressed in the non-luminal epithelial areas as well as in the myxoid and chondroid areas, but not in the truly mesenchymal tissues. These findings suggest that aggrecan is the most widely distributed PG in PA and may be produced mainly by non-luminal tumor cells. The absence of aggrecan from the truly mesenchymal tissues argues against its origin from this source. Both aggrecan and biglycan may play important roles in the chondroid differentiation and morphogenesis of PA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890456     DOI: 10.1111/j.1600-0714.1999.tb01992.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  8 in total

1.  The effect of proteoglycans inhibited by RNA interference on metastatic characters of human salivary adenoid cystic carcinoma.

Authors:  Hong Shi; Jie Wang; Fusheng Dong; Xu Wang; Hexiang Li; Yali Hou
Journal:  BMC Cancer       Date:  2009-12-21       Impact factor: 4.430

2.  Cartilage-specific matrix protein chondromodulin-I is associated with chondroid formation in salivary pleomorphic adenomas: immunohistochemical analysis.

Authors:  K Kusafuka; Y Hiraki; C Shukunami; A Yamaguchi; T Kayano; T Takemura
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

3.  Immunohistochemical evaluation of cartilage-derived morphogenic protein-1 and -2 in normal human salivary glands and pleomorphic adenomas.

Authors:  Kimihide Kusafuka; Franck P Luyten; Raymond De Bondt; Yuji Hiraki; Chisa Shukunami; Teruo Kayano; Tamiko Takemura
Journal:  Virchows Arch       Date:  2003-04-18       Impact factor: 4.064

4.  Inhibitory effects of Azadirachta indica on DMBA-induced skin carcinogenesis in Balb/c mice.

Authors:  Ashwani Koul; Nupur Mukherjee; Subhash Chander Gangar
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

5.  Ultrastructural immunolocalization of a cartilage-specific proteoglycan, aggrecan, in salivary pleomorphic adenomas.

Authors:  Koji Muramatsu; Kimihide Kusafuka; Hideto Watanabe; Toru Mochizuki; Takashi Nakajima
Journal:  Med Mol Morphol       Date:  2009-03-18       Impact factor: 2.309

6.  Transcription factors related to chondrogenesis in pleomorphic adenoma of the salivary gland: a mechanism of mesenchymal tissue formation.

Authors:  Yuka Matsumoto; Sunao Sato; Takashi Maeda; Mitsunobu Kishino; Satoru Toyosawa; Yu Usami; So-ichi Iwai; Mitsuhiro Nakazawa; Yoshiaki Yura; Yuzo Ogawa
Journal:  Lab Invest       Date:  2015-10-26       Impact factor: 5.662

7.  Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma.

Authors:  G Gannot; I Gannot; H Vered; A Buchner; Y Keisari
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

8.  Juvenile pleomorphic adenoma of masticator space: The first case report.

Authors:  Rajat G Panigrahi; Sujit Ranjan Sahoo; Swagatika Panda; Sthitaprajna Lenka; Subrat Kumar Padhiary; Ruchi Bhuyan; Sanat Bhuyan
Journal:  Contemp Clin Dent       Date:  2013-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.